ArticlePublic health challenges2022
Burden and unmet needs in asthma care in the Asia-Pacific region.
Article in Public health challenges, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Asthma is under-recognized and undermanaged in the Malaysian university population: A comparison of findings from Malaysia against Singapore from the Singapore/Malaysia cross-sectional genetic epidemiology study.The World Allergy Organization journal · 2026Article
- Assessment of knowledge on self-management and level of asthma control among patients attending a tertiary care center in Nepal: A cross-sectional study.PLOS global public health · 2026Article
- A Retrospective Study Evaluating Asthma Control in Patients on Fluticasone Propionate/Salmeterol Proactive Regular Dosing with a History of Uncontrolled Asthma.Pulmonary therapy · 2025Article
- Article
- Information Needs of State-Level Asthma Programs: Recommendations to Increase Accessibility.International journal of environmental research and public health · 2024Article
- Burden and unmet needs in asthma care in the Asia-Pacific region.Public health challenges · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Asthma is a chronic respiratory disease with increasing global prevalence. It affects approximately 300 million people globally and more than a third of these patients have uncontrolled asthma. The burden of poorly controlled asthma is considerable both for the individuals and the society. The World Health Organization (WHO) estimates that, 455,000 people died from asthma worldwide in 2019, the majority in low and low-middle-income countries. This article highlights the unmet needs and burden of asthma in the Asia-Pacific region where many patients have poorly controlled asthma despite advances in asthma care and treatment. A mismatch between patients' (and physicians') perception of asthma control and optimal asthma control as defined by the Global Initiative for Asthma (GINA) is a challenge in the real-life management of many patients. Consequently, treatment adherence and optimization are affected. In many of these aspects, patients with asthma in the Asia-Pacific region are comparatively worse than those from Europe and North America. In future, cooperation of all stakeholders is needed in improving awareness, education, and goal-directed management of asthma with meaningful improvement in quality of life. This article draws attention to some of the important gaps in asthma management in the Asia-Pacific region and suggests some measures to address these unmet needs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.